This is not to say that LIF and LIFRβ are not relevant; however, but rather that the focus of the conversation surrounding them in cancer should be shifted towards how LIF and LIFR can be understood through the lens of tumor suppression and promotion via the less understood Hippo pathway. The gene discussed is LIF; the disease is neoplasm.